S9: #085: Accelerating Digital Transformation in the Pharmaceutical Industry
Take a look online and you’ll find hundreds of articles proclaiming that Pharma’s business model is broken and that the entire sector is in the middle of an innovation crisis. Whether you agree or disagree, there’s no question that the industry is extraordinarily competitive and the challenge of bringing effective drugs to market is growing. Adapting to new ways of working and driving new tech and innovation across an entire industry is never easy, and with the long development cycles for new drugs and the low drug development success rates, the challenges are even bigger. But where some see a crisis, others see opportunity, and making the most of that opportunity can take many different forms and approaches.
In this episode, I speak with Jake LaPorte – someone who sees that opportunity and has developed a new program to give innovative digital health companies a boost.
Jake is the Global Head of Digital Development at Novartis and responsible for leading the company’s digital efforts within their Global Drug Development organization. He also is one of the founders and the Managing Director of BIOME—which is the first-ever, externally branded innovation lab by Novartis.
Jake completed his Ph.D. in Organic Chemistry from Harvard University, and received his B.Sc. in Biochemistry and Mathematics, from the University of Delaware. While traveling with his wife, he read Ray Kurzweil’s book The Singularity is Near and he became captivated by the possibility of digitizing the Pharmaceutical engine.
Ever since reading that book, Jake has focused his career on making that concept a reality. In this episode, he explains how the Novartis Biome is making a real impact on accelerating digital health solutions in drug development and discovery.
Get the full show notes here.
Digital Health Today is made possible by the support of our sponsors. Thank you!
Learn more about your ad choices. Visit megaphone.fm/adchoices